Cargando…
Paeoniflorin alleviates the progression of retinal vein occlusion via inhibiting hypoxia inducible factor-1α/vascular endothelial growth factor/STAT3 pathway
Retinal vein occlusion (RVO) is a severe retinal vascular disease involving several complications, leading to weakening of vision and even blindness. Globally, over 16 million patients with RVO were found in the middle-aged population. Paeoniflorin (PF), a monomer of Taohong Siwu decoction, was repo...
Autores principales: | Kong, Lingchun, Li, Jingjing, Yang, Yuqin, Tang, Huixin, Zou, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275925/ https://www.ncbi.nlm.nih.gov/pubmed/35653799 http://dx.doi.org/10.1080/21655979.2022.2081755 |
Ejemplares similares
-
Puerarin suppresses hypoxia-induced vascular endothelial growth factor upregulation in human retinal pigmented epithelial cells by blocking JAK2/STAT3 pathway
por: Tang, Huixin, et al.
Publicado: (2022) -
Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
por: Kim, Moosang
Publicado: (2016) -
Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors
por: Spooner, Kimberly, et al.
Publicado: (2019) -
Improving blood flow in occluded veins to reduce anti-vascular endothelial growth factor injections for branch retinal vein occlusion
por: Maeno, Takatoshi, et al.
Publicado: (2023) -
Intraocular cytokines in retinal vein occlusion and its relation to the efficiency of anti-vascular endothelial growth factor therapy
por: Shchuko, Andrey G, et al.
Publicado: (2015)